Brain-targeting biomimetic disguised manganese dioxide nanoparticles via hybridization of tumor cell membrane and bacteria vesicles for synergistic chemotherapy/chemodynamic therapy of glioma

Glioma is a prevalent brain malignancy associated with poor prognosis. Although chemotherapy serves as the primary treatment for brain tumors, its effectiveness is hindered by the limited ability of drugs to traverse the blood-brain barrier (BBB) and the development of drug resistance linked to tumor hypoxia. Herein, we report the creation of hybrid camouflaged multifunctional nanovesicles comprising membranes of tumor C6 cells (mT) and Bacterial outer membrane vesicles (OMVs) and co-loaded with manganese dioxide nanoparticles (MnO₂ NPs) and doxorubicin (DOX) to synergistically enhance the chemotherapy/chemodynamic therapy (CDT) of glioma. Owing to OMV-mediated BBB penetration and mT-inherited tumor-homing properties, MnO₂-DOX@mT/OMVs can penetrate the BBB and enhance the tumor cell-specific uptake of DOX via "proton Sponge effect"-mediated lysosomal escape. This enhances the apoptotic effect induced by DOX and minimizing DOX-associated cardiotoxicity by facilitating the accumulation of DOX at the tumor site. Furthermore, the MnO₂ NPs in MnO₂-DOX@mT/OMVs can generate potent CDT by accelerating the Fenton-like reaction with DOX-generated H₂O₂ and achieving glutathione (GSH)-depletion-induced Glutathione Peroxidase 4 (GPX4) inactivation. These results showed that MnO₂-DOX@mT/OMVs, designed for brain tumor targeting, significantly inhibited tumor growth and exhibited favorable biological safety. This innovative approach offers the augmentation of Anticancer treatment efficacy via a potential combination of chemotherapy and CDT.

Chemodynamic therapy; DOX; Glioma; Manganese dioxide; Nanoparticles; Nanovesicles.